Skip to main content
Caplight Logo









Vakona

Vakona

Private
UmeåHealthcare & Life Scienceshttps://vakona.se/

Last Round

VC Round

Apr 28, 2025

Total Funding Raised

$1.73M

Company Overview

Vakona is a pharmaceutical company developing a novel, antibiotic-free treatment for acne vulgaris by targeting bacterial biofilms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyacne treatmentdrug discoverytopical drugantibiotic-freebiofilmdermatologyacne vulgarispreclinical developmentbiotech startupmicrobiomepharma R&Dskincare techdrug candidate

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vakona Comparables

Compare Vakona with similar companies based on industry and business-model similarity.

Vakona comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Derm-Biome Pharmaceuticals
79%
AOBiome Therapeutics Inc.
73%
Dermata Therapeutics, Inc.
71%

Vakona Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 28, 2025
VC RoundMar 29, 2023
SeedNov 8, 2021

Key People

Founding team and executive leadership

Gabriella Persson

CEO

Executive Team

Vakona Investors

Notable investors and investment history

Vakona investors
InvestorRounds
Phase2Phase BiopharmaSeed, VC Round
Stockholm Business AngelsSeed, VC Round
Partnerinvest NorrSeed, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 29, 2023

    $1.33M round from Partnerinvest Norr and others.

Vakona Filings

Explore SEC and related filing metadata, where available.

Vakona filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vakona's valuation, stock price, and market status.

Is Vakona a public or private company?

Vakona is a private company.

What is the current stock price of Vakona?

Vakona is a private company with no public stock price. No recent secondary market data is available.

How much is Vakona worth (valuation)?

Valuation information for Vakona is not publicly available.

Can I buy Vakona stock?

Vakona shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vakona's last funding round?

Vakona's most recent funding round was VC Round on April 28, 2025.

Who are the main investors in Vakona?

Key investors in Vakona include Phase2Phase Biopharma, Stockholm Business Angels, Partnerinvest Norr.

Will Vakona IPO soon?

No public IPO plans have been announced for Vakona.

How can I track Vakona secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vakona's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUmeå
Employee Range6
Year Founded2020
Last FundingApr 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?